Summary The coronavirus disease 2019 (COVID-19) pandemic has shattered the
meticulously developed processes by which we delivered quality care for patients with …

The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World
Health Organization to define ambitious targets for eliminating HCV as a public health threat …

Background Increasing access to hepatitis C virus (HCV) care and treatment will require
simplified service delivery models. We aimed to evaluate the effects of decentralisation and …

Background & Aims HCV reinfection following successful treatment can compromise
treatment outcomes. This systematic review assessed the rate of HCV reinfection following …

Globally, some 71 million people are chronically infected with hepatitis C virus (HCV).
Marginalized populations, particularly people who inject drugs (PWID), have low testing …

Hepatitis C virus (HCV) is a global public health problem in correctional settings. The
International Network on Health and Hepatitis in Substance Users–Prisons Network is a …

Hepatitis C has a relevant global impact in terms of morbidity, mortality and economic costs,
with more than 70 million people infected worldwide. In the resolution,“Transforming our …

Abstract Background In England, opt-out dry blood spot prison screening for HIV, hepatitis B
and hepatitis C (HCV) has been introduced to scale-up access to care. Recent advances in …

Background Injection drug use (IDU) following treatment for hepatitis C virus (HCV) infection
may lead to reinfection, particularly if access to harm reduction services is suboptimal. This …

Abstract The World Health Organization has set tremendous goals to eliminate viral hepatitis
by 2030. However, most countries are currently off the track for achieving these goals …